Erasca, Inc.

NASDAQ:ERAS

Biotechnology

Healthcare
$13.76 -0.14%

-$0.02 today

Market cap
$4.83B
Beta
0.73
P/E (TTM)
-15.3
EPS (TTM)
-$0.91
52W Low $1.21High $24.28

Volume 8.94M

Average 6.79M

ERAS EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How ERAS compares with its peers on the latest reported figures

ERAS Competitors Peer median
EBITDA Margin for ERAS and competitors
Company Period LTM level YoY 3-year change
IDYAIDEAYA Biosciences, Inc.LTM Mar 2026-60.1% +4260.2 pp+61.2 pp
NUVBNuvation Bio Inc.LTM Jun 2026-74.8% +1326.6 pp—
TNGXTango Therapeutics, Inc.FY2025-159.2% +144.1 pp+269.3 pp
VSTMVerastem, Inc.LTM Mar 2026-387.1% +1063.3 pp+2084.9 pp
KURAKura Oncology, Inc.LTM Mar 2026-408.0% -146.3 pp—
ERASErasca, Inc.FY2025— ——
RVMDRevolution Medicines, Inc.FY2025— ——
ORICORIC Pharmaceuticals, Inc.FY2025— ——
AVBPArriVent BioPharma, Inc. Common StockFY2025— ——
Peer median (excluding ERAS) -159.2%+1063.3 pp+269.3 pp

Competitors are the stored peer set for ERAS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue829K2.64M3.73M03.11M
Gross Profit(829K)(2.64M)(3.73M)0(3.11M)
Gross Margin—————
Research & Development73.92M112.46M103.82M115.36M92.85M
Selling, General & Admin22.62M32.99M37.7M41.73M38.55M
Operating Expenses124.05M244.81M137.79M179.59M128.3M
Depreciation & Amortization829K2.64M3.73M3.81M3.11M
EBITDA(121.94M)(240.16M)(121.31M)(153.28M)(121.44M)
EBITDA Margin—————
Operating Income(124.88M)(247.45M)(141.53M)(179.59M)(131.41M)
Operating Margin—————
Interest Income190K4.9M16.71M20.09M16.61M
Interest Expense0201.36M000
Other Income / Expenses2.12M4.65M16.48M17.94M6.86M
Income Before Tax(122.76M)(242.81M)(125.04M)(161.65M)(124.55M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(122.76M)(242.81M)(125.04M)(161.65M)(124.55M)
Net Margin—————
EPS (Basic)(1.03)(1.99)(0.83)(0.69)(0.44)
EPS (Diluted)(1.03)(1.99)(0.83)(0.69)(0.44)
Weighted Avg Shares119.1M122.02M150.18M233.82M283.53M
Weighted Avg Shares (Diluted)119.1M122.02M150.18M233.82M283.53M

Erasca, Inc.

NASDAQ:ERAS

Intrinsic Alpha fair value

Locked

Current Price

$13.76

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.